Skip to main content
An official website of the United States government

Mignon Lee-Cheun Loh

An Asian woman with light skin tone wearing a blue blazer (Dr. Mignon Lee-Cheun Loh) smiles at the camera at an outdoor conference event.

For Dr. Mignon Lee-Cheun Loh, CCDI presents opportunities to sequence patients’ leukemias and contribute data that could generate meaningful predictions and impact patient care.

Credit: National Cancer Institute
  • Center Director, Ben Towne Center for Childhood Cancer Research
  • Chief, Division of Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy, Seattle Children’s Hospital

“Looking back, my whole career has been about data sharing,” said Dr. Mignon Lee-Cheun Loh (she/her), who has worked with colleagues worldwide to collect leukemia-specific patient data over time. Even in medical school, she knew she wanted to work in pediatric oncology. Since then, she’s treated children with different childhood cancer types, from the most common to the rarest.

Inspired by her patients’ resilience, Mignon leads breakthrough research in leukemia to understand the genetic landscape of cancer and determine treatment intensity. She's also using genomic discoveries to identify potential new leukemia drugs.

For her, CCDI presents “awesome opportunities to sequence patients’ leukemias at diagnosis and relapse,” said Mignon. “We can then contribute to databases and collaborate with those who specialize in data analysis to come up with meaningful predictions.”

  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Mignon Lee-Cheun Loh was originally published by the National Cancer Institute.”

Email